PriceTargets.com logo

LON:SPEC - INSPECS Group Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 425
  • Forecasted Upside: 99.53 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
GBX 213 As of 08/12/2022 01:00 AM ET
▼ -2 (-0.93%)

This chart shows the closing price for SPEC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New INSPECS Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SPEC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SPEC

Analyst Price Target is GBX 425
▲ +99.53% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for INSPECS Group in the last 3 months. The average price target is GBX 425, with a high forecast of GBX 425 and a low forecast of GBX 425. The average price target represents a 99.53% upside from the last price of GBX 213.

This chart shows the closing price for SPEC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 investment analysts is to buy stock in INSPECS Group.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/18/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/19/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/17/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/15/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/13/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/14/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/13/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/12/2022

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/8/2021Peel HuntReiterated RatingBuyGBX 425
10/28/2021Peel HuntReiterated RatingBuyGBX 425
10/28/2021Peel HuntReiterated RatingBuyGBX 425
7/10/2020Peel HuntReiterated RatingBuy
5/12/2020Peel HuntReiterated RatingBuy
(Data available from 8/12/2017 forward)

News Sentiment Rating

0.67 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/14/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/13/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/15/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/14/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/14/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
6/13/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/13/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/12/2022

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
INSPECS Group logo
INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear and original equipment manufacturer products. It provides a range of branded and private label optical and sunglasses frames, as well as lens products. The company offers its eyewear under the Viktor & Rolf, Valerie, Ivana Helsinki, Lyle & Scott, Barbour, Day Birger, Liberty London, Henri Lloyd, Et Mikkelsen, Caterpillar, and BOTANIQ brand names. INSPECS Group plc sells its products directly to retailers, distributors, and brand partners, as well as through e-commerce channel. The company sells its products through a network of approximately 75,000 retail outlets in 80 countries worldwide. INSPECS Group plc was founded in 1988 and is headquartered in Bath, the United Kingdom.
Read More

Today's Range

Now: GBX 213
Low: 210
High: 216

50 Day Range

MA: GBX 268.67
Low: 210
High: 345

52 Week Range

Now: GBX 213
Low: 210
High: 420

Volume

323,307 shs

Average Volume

60,527 shs

Market Capitalization

£216.56 million

P/E Ratio

N/A

Dividend Yield

0.57%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of INSPECS Group?

The following Wall Street research analysts have issued stock ratings on INSPECS Group in the last year: Peel Hunt, and Peel Hunt LLP.
View the latest analyst ratings for SPEC.

What is the current price target for INSPECS Group?

2 Wall Street analysts have set twelve-month price targets for INSPECS Group in the last year. Their average twelve-month price target is GBX 425, suggesting a possible upside of 99.5%. Peel Hunt has the highest price target set, predicting SPEC will reach GBX 425 in the next twelve months. Peel Hunt has the lowest price target set, forecasting a price of GBX 425 for INSPECS Group in the next year.
View the latest price targets for SPEC.

What is the current consensus analyst rating for INSPECS Group?

INSPECS Group currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SPEC will outperform the market and that investors should add to their positions of INSPECS Group.
View the latest ratings for SPEC.

What other companies compete with INSPECS Group?

Other companies that are similar to INSPECS Group include Tristel, Advanced Medical Solutions Group, Verona Pharma plc (VRP.L), Redx Pharma and Medica Group. Learn More about companies similar to INSPECS Group.

How do I contact INSPECS Group's investor relations team?

The company's listed phone number is 44 1125 717 000. The official website for INSPECS Group is inspecs.com. Learn More about contacing INSPECS Group investor relations.